Hal Galbraith

Safety and Pharmacokinetics of Bevirimat (PA-457), a Novel Inhibitor of Human Immunodeficiency Virus Maturation, in Healthy Volunteers

David E. Martin, Robert A. Blum, John H. Wilton et al. · Antimicrobial Agents and Chemotherapy · 2007 · 75 citations · Full text

Multiple-Dose Pharmacokinetics and??Safety of Bevirimat, a??Novel??Inhibitor??of??HIV Maturation,??in??Healthy??Volunteers

David E. Martin, Robert A. Blum, Judy Doto et al. · Clinical Pharmacokinetics · 2007 · 52 citations

Treatment And Prevention, Medicine, Antiviral Therapy +5

Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota

Barbara Lomeli, Hal Galbraith, Jared Schettler et al. · Antimicrobial Agents and Chemotherapy · 2019 · 35 citations · Full text

Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic Impairment

Enrique Grande, R. Donald Harvey, Benoît You et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 22 citations · Full text

Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Tommy Andersson, Péter Nagy, Mohammad Niazi et al. · American Journal of Cardiovascular Drugs · 2014 · 17 citations

Molecular Pharmacology, Pharmacological Study, Healthy Volunteers +4